PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
PDF) P743 What information is available on the internet and social media for faecal microbiota transplantation?
Untitled
Congresses & Events
Home
Home
Introduction
Kevin Whelan on Twitter: "Interested to learn more about #IBD? Prof James Lindsay promotes use of the ECCO-e learning platform https://t.co/f6faP7NIRI #IBDdiet #ECCO… https://t.co/veMvbyI8WR"
PDF) Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD | Giovanni Latella and Giorgos Bamias - Academia.edu
Home
ECCO News
PDF) P698 Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn's disease and ulcerative colitis patients
Inflammatory Bowel Diseases 2014 Bella Center Copenhagen, Denmark EACCME applied Register online at - ppt download
PDF) P728 Changes in the use of biologics in the treatment of IBD patients over time. Results from a comprehensive Norwegian registry study
PDF) P775 Evolution of inflammatory bowel disease research from a bird's eye perspective: A text-mining analysis of publication trends and topics
Current cv2016 (2)
PDF) ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease
N029 Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD) N030 Real benefi
Past Congresses
Past Congresses
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Home
Journal of Crohn's and Colitis | ScienceDirect.com by Elsevier
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
